Diagnostic performance of magnetic resonance first pass perfusion imaging is equally potent in female compared to male patients with coronary artery disease

[1] Lerner DJ(1986)Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population Am Heart J 111 383-390

[2] Kannell WB(2002)ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise testing Guidelines) Circulation 106 1883-1892

[3] Gibbons RJ(1999)Meta-analysis of exercise testing to detect coronary artery disease in women Am J Cardiol 83 660-666

[4] Balady GJ(2005)Role of non-invasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association Circulation 111 682-696

[5] Bricker JT(2001)Pharmacologic stress testing for coronary artery disease: a meta-analysis Am Heart J 142 934-944

[6] Chaitman BR(1997)Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women J Am Coll Cardiol 29 69-77

[7] Fletcher GF(1998)Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men J Nucl Med 39 751-755

[8] Froehlicher VF(2007)Assessment of myocardial perfusion for detection of coronary artery stenoses by steady state, free-precession magnetic resonance first-pass imaging Heart 93 1381-1385

[9] Mark DB(2008)Adenosine stress cardiac magnetic resonance imaging for the assessment of ischemic heart disease Clin Res Cardiol 97 905-912

[10] McCallister BD(2006)Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography Clin Res Cardiol 95 531-538

[1] Lerner DJ(1986)Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population Am Heart J 111 383-390

[2] Kannell WB(2002)ACC/AHA 2002 guideline update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise testing Guidelines) Circulation 106 1883-1892

[3] Gibbons RJ(1999)Meta-analysis of exercise testing to detect coronary artery disease in women Am J Cardiol 83 660-666

[4] Balady GJ(2005)Role of non-invasive testing in the clinical evaluation of women with suspected coronary artery disease: consensus statement from the Cardiac imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association Circulation 111 682-696

[5] Bricker JT(2001)Pharmacologic stress testing for coronary artery disease: a meta-analysis Am Heart J 142 934-944

[6] Chaitman BR(1997)Comparative diagnostic accuracy of Tl-201 and Tc-99m sestamibi SPECT imaging (perfusion and ECG-gated SPECT) in detecting coronary artery disease in women J Am Coll Cardiol 29 69-77

[7] Fletcher GF(1998)Diagnostic accuracy of technetium-99m-MIBI myocardial SPECT in women and men J Nucl Med 39 751-755

[8] Froehlicher VF(2007)Assessment of myocardial perfusion for detection of coronary artery stenoses by steady state, free-precession magnetic resonance first-pass imaging Heart 93 1381-1385

[9] Mark DB(2008)Adenosine stress cardiac magnetic resonance imaging for the assessment of ischemic heart disease Clin Res Cardiol 97 905-912

[10] McCallister BD(2006)Clinical implication of adenosine-stress cardiac magnetic resonance imaging as potential gatekeeper prior to invasive examination in patients with AHA/ACC class II indication for coronary angiography Clin Res Cardiol 95 531-538